Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02547402 · ClinicalTrials.gov registry record · Phase 1
A Study of the PK Interaction of CXA-10 With Pravastatin and Vytorin® in Healthy Males
A Phase 1 study of Acute Kidney Injury, sponsored by Complexa.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT02547402: Completed Phase 1 study of Acute Kidney Injury, sponsored by Complexa.
NCT02547402 is a Phase 1 study of Acute Kidney Injury that has completed, run by Complexa. The registered enrollment target is 10 participants, below the 2,331-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02547402, a Phase 1 study of Acute Kidney Injury, has completed, sponsored by Complexa.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an exploratory study in a small, well controlled group of healthy subjects to explore the effect of CXA-10 on pravastatin and Vytorin® (combination of simvastatin and ezetimibe).
Conditions Studied
Interventions
- DRUG CXA-10
- DRUG pravastatin
- DRUG Vytorin® (combination of simvastatin and ezetimibe)
Study Locations (1)
Michigan
- Jasper Clinical Research & Development, Inc. - Kalamazoo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2015-12 |
| Est. Completion | 2016-02 |
| Phase | Phase 1 |
What the finished NCT02547402 record still lists
NCT02547402 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 2,331-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Acute Kidney Injury appearing as the primary indexed condition, and to 3 interventions - of which CXA-10 is the first listed.
NCT02547402 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT02547402 about?
NCT02547402 is a clinical study titled "A Study of the PK Interaction of CXA-10 With Pravastatin and Vytorin® in Healthy Males". This is an exploratory study in a small, well controlled group of healthy subjects to explore the effect of CXA-10 on pravastatin and Vytorin® (combination of simvastatin and ezetimibe).
What is the current status of trial NCT02547402?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2015-12. Estimated completion is 2016-02.
What conditions does trial NCT02547402 study?
This clinical trial studies the following conditions: Acute Kidney Injury.
What interventions are being tested in trial NCT02547402?
The interventions under investigation include: CXA-10 (DRUG), pravastatin (DRUG), Vytorin® (combination of simvastatin and ezetimibe) (DRUG).
Who is sponsoring clinical trial NCT02547402?
This trial is sponsored by Complexa, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02547402 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Kidney Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02547402's enrollment target sits among peer trials
10 74th of 74 the lowest of 74 other Acute Kidney Injury trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Kidney Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Theophylline Prophylaxis During Hypothermia to Limit Neonatal Nephron Damage
RECRUITING · Phase 1
-
Allogeneic HB-adMSCs vs Placebo for the Treatment of Acute Kidney Injury
RECRUITING · Phase 1
-
Ibuprofen and Biomarkers of Acute Kidney Injury After Running in the Heat
COMPLETED · Phase 1
-
Pharmacokinetics of MP-3180 and Use of Noninvasive Fluorescence Detection Device in Healthy Volunteers
COMPLETED · Phase 1
-
Ultra-Low Contrast Angiography in AKI
RECRUITING · Phase 3
-
Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia